• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

资源建模:卫生技术评估拼图中缺失的一块?

Resource modelling: the missing piece of the HTA jigsaw?

作者信息

Thokala Praveen, Dixon Simon, Jahn Beate

机构信息

Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK,

出版信息

Pharmacoeconomics. 2015 Mar;33(3):193-203. doi: 10.1007/s40273-014-0228-9.

DOI:10.1007/s40273-014-0228-9
PMID:25411095
Abstract

Within health technology assessment (HTA), cost-effectiveness analysis and budget impact analyses have been broadly accepted as important components of decision making. However, whilst they address efficiency and affordability, the issue of implementation and feasibility has been largely ignored. HTA commonly takes place within a deliberative framework that captures issues of implementation and feasibility in a qualitative manner. We argue that only through a formal quantitative assessment of resource constraints can these issues be fully addressed. This paper argues the need for resource modelling to be considered explicitly in HTA. First, economic evaluation and budget impact models are described along with their limitations in evaluating feasibility. Next, resource modelling is defined and its usefulness is described along with examples of resource modelling from the literature. Then, the important issues that need to be considered when undertaking resource modelling are described before setting out recommendations for the use of resource modelling in HTA.

摘要

在卫生技术评估(HTA)中,成本效益分析和预算影响分析已被广泛视为决策的重要组成部分。然而,尽管它们涉及效率和可承受性问题,但实施和可行性问题在很大程度上被忽视了。HTA通常在一个审议框架内进行,该框架以定性方式处理实施和可行性问题。我们认为,只有通过对资源限制进行正式的定量评估,这些问题才能得到充分解决。本文认为有必要在HTA中明确考虑资源建模。首先,描述了经济评估和预算影响模型及其在评估可行性方面的局限性。接下来,定义了资源建模,并描述了其有用性以及文献中的资源建模示例。然后,在提出HTA中使用资源建模的建议之前,描述了进行资源建模时需要考虑的重要问题。

相似文献

1
Resource modelling: the missing piece of the HTA jigsaw?资源建模:卫生技术评估拼图中缺失的一块?
Pharmacoeconomics. 2015 Mar;33(3):193-203. doi: 10.1007/s40273-014-0228-9.
2
[Health technology assessment (HTA). Developments in healthcare and potential for radiology].[卫生技术评估(HTA)。医疗保健领域的发展及放射学的潜力]
Radiologe. 2014 Jun;54(6):589-98. doi: 10.1007/s00117-014-2695-6.
3
[Health economics and HTA].[卫生经济学与卫生技术评估]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006 Mar;49(3):257-63. doi: 10.1007/s00103-005-1228-x.
4
Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.用于卫生技术评估的多标准决策分析(MCDA):昆士兰卫生部门的经验
Aust Health Rev. 2019 Oct;43(5):591-599. doi: 10.1071/AH18042.
5
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.
6
Evidence-based decision-making 3: Health technology assessment.循证决策3:卫生技术评估。
Methods Mol Biol. 2015;1281:417-41. doi: 10.1007/978-1-4939-2428-8_25.
7
Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment.将可负担性问题纳入卫生技术评估的成本效益分析中。
Value Health. 2019 Aug;22(8):898-905. doi: 10.1016/j.jval.2019.05.003. Epub 2019 Jul 30.
8
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.预算影响分析良好实践原则:ISPOR良好研究实践特别工作组——预算影响分析报告
Value Health. 2007 Sep-Oct;10(5):336-47. doi: 10.1111/j.1524-4733.2007.00187.x.
9
Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.识别并揭示卫生技术评估决策标准的重要性:爱尔兰报销建议的回顾性分析
Pharmacoeconomics. 2016 Sep;34(9):925-37. doi: 10.1007/s40273-016-0406-z.
10
Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment.基于离散事件仿真的卫生技术评估中的资源建模。
Pharmacoeconomics. 2017 Oct;35(10):989-1006. doi: 10.1007/s40273-017-0533-1.

引用本文的文献

1
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations.在卫生经济评估中纳入资源约束:概述与方法学考量
Pharmacoecon Open. 2025 Mar;9(2):161-178. doi: 10.1007/s41669-024-00537-z. Epub 2024 Dec 17.
2
Economic Assessment in Resource-Constrained Systems: Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema.资源受限系统中的经济评估:湿性年龄相关性黄斑变性和糖尿病性黄斑水肿的个体水平模拟模型
Ophthalmol Ther. 2024 Oct;13(10):2577-2597. doi: 10.1007/s40123-024-00999-8. Epub 2024 Aug 6.
3
Constrained Optimization for Decision Making in Health Care Using Python: A Tutorial.

本文引用的文献

1
Impact of the National Institute for Health and Care Excellence (NICE) guidance on medical technology uptake: analysis of the uptake of spinal cord stimulation in England 2008-2012.英国国家卫生与临床优化研究所(NICE)指南对医疗技术采用情况的影响:2008 - 2012年英格兰脊髓刺激疗法采用情况分析
BMJ Open. 2014 Jan 7;4(1):e004182. doi: 10.1136/bmjopen-2013-004182.
2
Hospital-based health technology assessment on the use of mitral clips in the treatment of mitral regurgitation.基于医院的二尖瓣夹治疗二尖瓣反流的卫生技术评估。
Technol Health Care. 2013;21(6):535-46. doi: 10.3233/THC-130756.
3
Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community.
使用 Python 进行医疗保健决策的约束优化:教程。
Med Decis Making. 2023 Oct-Nov;43(7-8):760-773. doi: 10.1177/0272989X231188027. Epub 2023 Jul 22.
4
Health technology assessment of new retinal treatments; the need to capture healthcare capacity issues.新型视网膜治疗的卫生技术评估;把握医疗保健能力问题的必要性。
Eye (Lond). 2022 Dec;36(12):2236-2238. doi: 10.1038/s41433-022-02149-5. Epub 2022 Jun 28.
5
ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients.ENTIMOS:用于优化治疗多发性硬化症患者的中心输液套房效率的离散事件模拟模型。
Appl Health Econ Health Policy. 2022 Sep;20(5):731-742. doi: 10.1007/s40258-022-00733-0. Epub 2022 May 19.
6
Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine.量化经济评估中容量限制的影响:精准医学的应用。
Med Decis Making. 2022 May;42(4):538-553. doi: 10.1177/0272989X211053792. Epub 2021 Oct 25.
7
Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach.英国丙型肝炎治疗资源的分配:一种约束优化建模方法。
J Mark Access Health Policy. 2021 Mar 25;9(1):1887664. doi: 10.1080/20016689.2021.1887664.
8
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.利用动态仿真模型解决精准医学中的经济评估挑战。
Value Health. 2020 May;23(5):566-573. doi: 10.1016/j.jval.2020.01.016. Epub 2020 Mar 26.
9
Cost-Effectiveness Thresholds: the Past, the Present and the Future.成本效益阈值:过去、现在和未来。
Pharmacoeconomics. 2018 May;36(5):509-522. doi: 10.1007/s40273-017-0606-1.
10
Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment.基于离散事件仿真的卫生技术评估中的资源建模。
Pharmacoeconomics. 2017 Oct;35(10):989-1006. doi: 10.1007/s40273-017-0533-1.
改善长期抑郁症服务的卫生经济建模创新:在当地卫生社区的示范。
BMC Health Serv Res. 2013 Apr 26;13:150. doi: 10.1186/1472-6963-13-150.
4
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.健康经济评估报告标准(CHEERS)——解释与说明:国际卫生经济学会健康经济评估报告指南良好报告实践工作组报告。
Value Health. 2013 Mar-Apr;16(2):231-50. doi: 10.1016/j.jval.2013.02.002.
5
Resource-use measurement based on patient recall: issues and challenges for economic evaluation.基于患者回忆的资源利用测量:经济评价面临的问题和挑战。
Appl Health Econ Health Policy. 2013 Jun;11(3):155-61. doi: 10.1007/s40258-013-0022-4.
6
Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland.利用资源建模为决策和服务规划提供信息:以爱尔兰结直肠癌筛查为例。
BMC Health Serv Res. 2013 Mar 19;13:105. doi: 10.1186/1472-6963-13-105.
7
The economic evaluation of medical devices: challenges ahead.医疗器械的经济评价:未来的挑战。
Appl Health Econ Health Policy. 2013 Feb;11(1):15-26. doi: 10.1007/s40258-012-0006-9.
8
Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.为 NICE 何时应仅在适当设计的证据开发计划背景下推荐使用卫生技术制定决策框架提供信息。
Health Technol Assess. 2012;16(46):1-323. doi: 10.3310/hta16460.
9
Development of a resource modelling tool to support decision makers in pandemic influenza preparedness: The AsiaFluCap Simulator.开发资源建模工具以支持大流行性流感防范决策制定者:亚洲流感能力建设模拟工具。
BMC Public Health. 2012 Oct 12;12:870. doi: 10.1186/1471-2458-12-870.
10
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5.动态传播建模:ISPOR-SMDM 建模良好实践工作组的报告——5.
Value Health. 2012 Sep-Oct;15(6):828-34. doi: 10.1016/j.jval.2012.06.011.